Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Fertil Steril. 2018 Nov;110(6):981-987. doi: 10.1016/j.fertnstert.2018.09.005.
Oocyte and embryo donation have evolved significantly since they were first introduced to treat human infertility nearly four decades ago. Social, ethical, and regulatory challenges to oocyte and embryo donation have generated controversy and invited public scrutiny. However, oocyte and embryo donation continued to provide physicians the opportunity to treat the "untreatable." Undoubtedly, clinical practices related to oocyte and embryo donation have greatly changed over the years. Yet, they have endured as viable choices of treatment for many patients and their physicians, remained popular owing to their versatility, and, perhaps most importantly, provided consistently high pregnancy success rates.
卵母细胞和胚胎捐赠自近 40 年前首次被引入用于治疗人类不孕以来已经有了显著的发展。卵母细胞和胚胎捐赠所带来的社会、伦理和监管方面的挑战引发了争议，并引起了公众的关注。然而，卵母细胞和胚胎捐赠仍然为医生提供了治疗“不治之症”的机会。毫无疑问，多年来，与卵母细胞和胚胎捐赠相关的临床实践已经发生了很大的变化。然而，它们作为许多患者及其医生的治疗选择仍然具有生命力，由于其多功能性而广受欢迎，也许最重要的是，它们一直保持着较高的妊娠成功率。
